Transforming Scientific Promise into Therapeutic Progress
Design Targeted Cell & Gene Therapies. Master Manufacturing. Accelerate Patient Access.
R&D • Manufacturing • Analytics • Clinical • Regulatory • Investment
EXCLUSIVE OFFER
First 50 therapeutic developers and emerging companies attending Cell and Gene Therapy International Europe are eligble for exclusive pricing:
- All Access Conference & Workshop Pass for CGTI Europe - £399.00
- All Access Conference Pass for CGTI Europe - £299.00
Gain the edge in bioprocessing innovation while maximizing your ROI through this limited-time opportunity at Europe's premier therapy development conference.
Cell & Gene Therapy International Europe Conference & Exhibit Hall
Join Europe's most influential cell and gene therapy innovators as they navigate regulatory challenges, address manufacturing hurdles, and accelerate therapeutic development beyond CAR-T and AAV therapies. Connect with decision-makers from leading pharmaceutical organisations, innovative CGT biotech companies, research centres and emerging start-ups collectively tackling the pressing challenges in scaling production and improving patient access to advanced therapies throughout Europe.
Brilliant Minds Behind Breakthrough Innovations: Our 2025 Speaker Showcase
Cell & Gene Therapy International Europe features thought leaders and innovators who are actively shaping the industry's future. We provide unparalleled access to cutting-edge research, regulatory insights, and manufacturing expertise specifically tailored to the European advanced therapy landscape.
Streamline Operations, Lower Costs & Scale Better -Advancing Cell & Gene Therapy Access
Explore the full spectrum of advanced therapies from development to production, learn how to optimise every phase and expand patient access like never before!
Your ticket includes access to all conference sessions, interactive discussions, and networking opportunities, plus 12 months of on-demand recordings to enhance your learning.
Cell Therapy
Discover cutting-edge solutions to revolutionise your autologous & allogeneic cell therapy manufacturing, from automated processes, decentralised manufacturing to rapid scale-up strategies with reduced costs and increased product quality.
Gene Therapy
Accelerate gene therapy production with breakthrough upstream and downstream innovations. Fast-track approvals through innovative analytics, process control and characterisation without compromising quality.
Breakthrough Therapy Showcase: 15 – Minute Power Sessions
Discover the next wave of revolutionary cell & gene therapies reshaping the future of medicine.
C-Level Executive Forum
Transform CGT challenges into opportunities in an exclusive closed door think tank of industry leaders and C-level innovators.
Master the Art of Seamless Tech Transfer
Optimise internal and external tech transfers: From risk management to digital transformation in this interactive post conference workshop.
Unlock the Science Behind Potency Assays
Enhance your expertise in designing, validating, and defending potency assays in this interactive post-conference workshop.
European Focus & Scaling
How does CGTI EU solve scalability and CoGs challenges in gene therapy manufacturing?
We provide technical case studies and interactive discussions from expanding the upstream toolboxes for high-productivity AAV production to advanced technologies, manufacturing advances, LNPs and enabling optimised purification strategies for full capsid enrichment that are dramatically reducing costs of goods for both rare disease and broader gene therapy patient populations.
How will this event help my organisation improve cell therapy manufacturing efficiency and scale operations in Europe?
Through case studies including our keynote presentation from “Building a CAR-T Manufacturing Facility from a Greenfield to Operation" by VP-General Manager EU at Legend Biotech and keynote panel discussions on regulatory landscapes, you'll gain practical insights on how to successfully scale your cell therapy manufacturing operations across European markets.
What scientific sessions are available on scaling allogeneic cell therapy production?
Our programme features case study insights from NextCell Pharma, Evotec, Plasticell and PDC*line Pharma on designing and scaling “off-the shelf” allogeneic cell therapies.
How can automation, AI and digitalisation transform cell and gene therapy manufacturing?
Artificial intelligence and digitalisation are transforming cell and gene therapy manufacturing through predictive analytics, digital twins, and machine learning models that enhance process control despite data limitations. CGTI EU evaluates opportunities to integrate AI in CGT manufacturing and goes beyond the hype with practical examples of their use for improving product quality whilst reducing development timelines.
Transforming Regenerative Medicine: Breaking Cell & Gene Therapy Industry News
ExCellThera's Breakthrough: Zemcelpro® Receives EC Authorisation for Blood Cancer Patients
ExCellThera's Zemcelpro® has received conditional marketing approval from European Commission, as the first cell therapy for blood cancer patients lacking suitable donor cells. This breakthrough expands access to potentially life-saving allogeneic transplants for adults with hematological malignancies requiring stem cell transplantation.
European Consortium EASYGEN Launches to Transform CAR-T Manufacturing
The €8 million EU-backed EASYGEN consortium brings together 18 partners including Fresenius and Charles River Laboratories to develop an automated, hospital-based CAR-T manufacturing platform. This initiative aims to reduce production time to under 24 hours while making these life-saving therapies more affordable and accessible across Europe.
Decentralized Manufacturing Act: Exclusive Regulatory Insights
Don't miss this exclusive opportunity to hear directly from Ian Rees, who led the Medicines and Healthcare products Regulatory Agency's (MHRA) development of the groundbreaking Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025
Cell & Gene Therapy International Europe by the Numbers
+
Global Attendees
+
Expert Speakers
+
Hours of Networking
Top Cell and Gene Therapy Innovator Companies Attended in 2024
Connect with Purpose: Transforming Intimate Conversations into Infinite Opportunities
NEW Roundtable Sessions
Engage in focused, small-group discussions with experts. Designed for deeper dialogue.
Your Burning Questions, Answered.
Want to know how to navigate the competitive funding and complex global regulatory landscape and position yourself for success?
Don’t miss our exciting Investor and Regulatory keynote panel discussions, debuting in 2025!
Showcase Your Research: Poster Presentations
Share your latest scientific discoveries with the CGT community —right at the heart of the exhibit hall.
Gain industry recognition and connect with leading experts to drive innovation forward.
Berlin: Where Collaborations Begin
Wrap up the day with a relaxing networking session over drinks, where casual conversations evolve into groundbreaking collaborations.
Newest Tech in R&D and Manufacturing
Our Exhibit Hall features 20+ exhibitors showcasing cutting-edge tech to fast-track your cell and gene therapies to commercial success.
ConnectMe: Your Gateway to Meaningful CGT Connections
Launching 4 weeks before the event, ConnectMe offers AI-powered matchmaking, real-time event updates, and an instant meeting scheduler —making it easier than ever to connect, collaborate, and maximize your event experience.
Engage a qualified audience of global cell and gene therapy executives and scientists!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals.
Contact Roshni Shah to learn more about sponsorship opportunities: RShah@informaconnectls.com
